Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-71.32%
↑ 100% vs avg
Percentile
P89
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
-19720.07%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -71.32% | +14.8% |
| 2024 | -83.72% | +29.6% |
| 2023 | -118.93% | +32.5% |
| 2022 | -176.28% | -51.0% |
| 2021 | -116.77% | -126.4% |
| 2020 | -51.58% | +86.3% |
| 2019 | -375.81% | -9.0% |
| 2018 | -344.81% | +97.1% |
| 2017 | -11964.51% | +93.5% |
| 2016 | -183896.99% | - |